Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01882881 · ClinicalTrials.gov registry record · NA

Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors

A NA study, sponsored by Penn State University.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT01882881: Completed NA study, sponsored by Penn State University.

NCT01882881 is a NA study that has completed, run by Penn State University. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01882881, a NA study, has completed, sponsored by Penn State University.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the individual and combined effects of dark chocolate/cocoa and almonds on lipids, lipoproteins, antioxidant defense, lipid peroxidation, phenolic acids, inflammatory status, blood pressure and arterial health. It is hypothesized that dark chocolate/cocoa and/or almonds will favorably affect lipids, lipoproteins, antioxidants, inflammatory status, blood pressure and arterial health compared to a healthy American control diet; however, the effects will be greater when dark chocolate/cocoa and almonds are consumed together versus consumption of each food individually.

Primary Outcome

Total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides

Interventions

  • OTHER Healthy American Control Diet
  • OTHER Dark Chocolate/Cocoa Diet
  • OTHER Almond Diet
  • OTHER Dark Chocolate/Cocoa + Almond Diet

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2012-03
Est. Completion 2016-08
Phase NA
Penn State University

219 total trials

What the finished NCT01882881 record still lists

NCT01882881 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 4 interventions - of which Healthy American Control Diet is the first listed.

NCT01882881 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01882881 about?

NCT01882881 is a clinical study titled "Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors". The purpose of this study is to investigate the individual and combined effects of dark chocolate/cocoa and almonds on lipids, lipoproteins, antioxidant defense, lipid peroxidation, phenolic acids, inflammatory status, blood pressure and arterial health. It is hypothesized that dark chocolate/cocoa ...

What is the current status of trial NCT01882881?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2012-03. Estimated completion is 2016-08.

What interventions are being tested in trial NCT01882881?

The interventions under investigation include: Healthy American Control Diet (OTHER), Dark Chocolate/Cocoa Diet (OTHER), Almond Diet (OTHER), Dark Chocolate/Cocoa + Almond Diet (OTHER).

Who is sponsoring clinical trial NCT01882881?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01882881's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01882881, the US trial registry maintained by the National Library of Medicine. NCT01882881 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.